Your position:
m.limatoxi.com
>>
EN
>>
Pharmaceutical News
>>
Company
>>
FDA cautions Aurobindo oral solids formulation facility
>> article
FDA cautions Aurobindo oral solids formulation facility
Editor:bianch Clicks:
0
Date:2020-2-19 15:40:22
Keyword:
FDA Aurobindo
Healthoo Information:
UserLogin
UserName：
Password：
The non-formal user may read the summary, the formal user can read the whole article。
please at once register the user of Heatlhoo.com
After registration, we will provide the sample reports and the more comprehensive consulting services for you.
UserName
Contact:
Title:
Mr.
Ms.
Password
Repeat password:
Mobile
Email
Verification code:
Company Name
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Aurobindo builds 2nd project at Taizhou
Nhwa received FDA warning Letter for 3 APIs
Lihua received import alert from FDA
Chuanning 4 APIs passed FDA authentication
Modern passed FDA examination
Huahai APIs passed FDA examination
Xianju passed US FDA authentication
Yangzhou's 7 APIs passed FDA authentication
Hanyu passed FDA examination first time
Haiteng's Dexrazoxane passed US FDA
Address: 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
map
